Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes.
- Published In:
- Peptides, 100, 150-157 (2018)
- Authors:
- Deacon, Carolyn F
- Database ID:
- RPEP-03642
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03642APA
Deacon, Carolyn F. (2018). Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes.. Peptides, 100, 150-157. https://doi.org/10.1016/j.peptides.2017.10.011
MLA
Deacon, Carolyn F. "Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes.." Peptides, 2018. https://doi.org/10.1016/j.peptides.2017.10.011
RethinkPeptides
RethinkPeptides Research Database. "Peptide degradation and the role of DPP-4 inhibitors in the ..." RPEP-03642. Retrieved from https://rethinkpeptides.com/research/deacon-2018-peptide-degradation-and-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.